Dimensional Fund Advisors
IRD

Dimensional Fund Advisors’s Opus Genetics IRD Stock Holding History

Dimensional Fund Advisors’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-25,592
Closed -$111K – 3513
2023
Q2 		$111K Hold
25,592
– – ﹤0.01% 3308
2023
Q1 		$96K Hold
25,592
– – ﹤0.01% 3308
2022
Q4 		$91 Buy
25,592
+16
+0.1% +$42 ﹤0.01% 3333
2022
Q3 		$51K Buy
+25,576
New +$55.2K ﹤0.01% 3403
2022
Q2 		– Sell
-16,575
Closed -$54K – 3538
2022
Q1 		$54K Hold
16,575
– – ﹤0.01% 3454
2021
Q4 		$62K Buy
+16,575
New +$66.5K ﹤0.01% 3475

Other funds holding IRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

Dimensional Fund Advisors's IRD Position: Q3 2023 in Review

Dimensional Fund Advisors sold out of Opus Genetics (IRD) in Q3 2023, closing a stake of 25,592 shares — an estimated $111K sold.

Dimensional Fund Advisors first reported a position in IRD in Q4 2021 and held it in 6 quarters. The position peaked at $111K in Q2 2023. 49 funds tracked by Wall St. Rank hold IRD as of Q3 2023.

  • Dimensional Fund Advisors reported no remaining Opus Genetics position as of Q3 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 25,592 Opus Genetics shares in Q3 2023, an estimated $111K.
  • Dimensional Fund Advisors first reported a position in Opus Genetics in Q4 2021 and held it in 6 quarters.
  • Dimensional Fund Advisors's Opus Genetics position peaked at $111K in Q2 2023.
  • 49 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2023.

Based on Dimensional Fund Advisors's 13F filing for Q3 2023, filed 9 Nov 2023.